TVRD — Tvardi Therapeutics Share News
0.000.00%
Last trade - 00:00Tvardi Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Tvardi Therapeutics up after Piper Sandler starts coverage
Brief: Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis
U.S. STOCKS ON THE MOVE-Xponential Fitness, Phillips 66, Amazon.com
U.S. STOCKS ON THE MOVE-Intuitive Surgical, Boeing, Abbott
U.S. STOCKS ON THE MOVE-Deere, Lockheed Martin, Alibaba.com
U.S. STOCKS ON THE MOVE-Walmart, Lockheed Martin, UnitedHealth Group
BTIG starts Tvardi's coverage with 'buy' as co's drug to reverse lung scarring shows promise
Brief: Tvardi Therapeutics Announces First Quarter 2025 Results And Provides Business Update
Tvardi Therapeutics Inc expected to post a loss of 35 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-StoneX, US automakers, Johnson & Johnson
Brief: Cara Therapeutics Announces 1-For-3 Reverse Stock Split
Cara Therapeutics rises after announcement of reverse stock split
Brief: Cara Therapeutics Inc - Receives Non-Compliance Notice From Nasdaq On Minimum Stockholders’ Equity Requirement
Cara Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Cara Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: CSL Limited Reports 13.5% Stake In Cara Therapeutics
Cara Therapeutics Inc reports results for the quarter ended in June - Earnings Summary